She Leads Biotech
Rethinking Eye Care: From NanoDropper to Mu Medical What started as a student project has turned into a company reshaping how eye care is delivered. In this episode of She Leads Biotech, we’re joined by Allisa Song, CEO of Mu Medical, and Mackenzie Andrews, CCO, to talk about the journey from an idea sparked in a research lab to a product now used across thousands of clinics. They share how a simple question, why are eye drops too big, led to a solution that improves patient outcomes, reduces waste, and is now evolving into something much bigger. We also get into co-founder dynamics, building in a complex healthcare system, and the reality of being young female leaders in a traditionally male-dominated space. A practical, honest conversation about building, scaling, and challenging assumptions in healthcare. Chapters 00:00 Introduction 01:30 Meet Allisa & Mackenzie 04:00 From Research Lab to Startup Idea 08:30 The Eye Drop Problem Explained 13:00 Building NanoDropper 18:30 When It Became a Real Business 22:00 Product Demo & Clinical Impact 26:00 Go-to-Market Strategy 30:00 Working with Insurers, Clinics & Pharma 34:00 Evolving into Mu Medical 38:00 Co-Founder Dynamics & Trust 42:00 Being Women in a Male-Dominated Industry 47:00 Advice for Founders 51:00 What’s Next for Mu Medical Listen / Watch: Spotify | YouTube #SheLeadsBiotech #MedTech #HealthcareInnovation #WomenInBiotech #CNAUSAExecutiveSearch
79 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y forma parte de la comunidad de She Leads Biotech!